专家对临床挑战的观点:血液恶性瘤和血管炎
Michelle L Robinette1,2,3, Hetty E Carraway4
1Division of Rheumatology, Inflammation, and Immunity, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Arthritis & rheumatology (Hoboken, N.J.)
|April 27, 2025
概括
系统性血管炎可以由癌症引发. 本综述讨论了与并发性血液性恶性瘤 (VCHM) 相关的血管炎,重点关注这些复杂病例的诊断和管理策略.
科学领域:
- 风湿病学和血液学/瘤学
- 罕见的自身免疫和血液病.
背景情况:
- 系统性血管炎涉及血管炎症,可能由恶性瘤引发.
- 血液恶性瘤是已知的血管炎的原因,称为与同时发生的血液恶性瘤 (VCHM) 相关的血管炎.
- 由于耐药性疾病和并发性疾病,VCHM存在诊断和治疗方面的挑战.
研究的目的:
- 概述一种协作方法来诊断和管理VCHM.
- 突出VCHM的复杂性,特别是在骨髓瘤瘤的背景下.
- 让风湿病学家了解这个不断发展的领域及其管理.
主要方法:
- 对VCHM现有文献的审查.
- 讨论了风湿病学和血液学/瘤学之间的协作诊断和管理策略.
- 专注于骨髓瘤新生病作为一个模型,对淋巴细胞关联的讨论有限.
主要成果:
- VCHM需要专门的,多学科的护理.
- 骨髓瘤形成是理解VCHM的一个相关模型.
- 血液学中分子诊断的增加需要风湿病学家的意识.
结论:
- VCHM是一种复杂的疾病,需要从风湿病学和血液学/瘤学方面提供综合护理.
- 风湿病学家必须意识到VCHM的诊断和治疗复杂性.
- 需要进一步的研究来完善VCHM的管理策略.
相关概念视频
Disorders of Hemostasis
638
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
638
Bone Marrow Sampling and Transplants
260
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
260
Regulation of Hematopoietic Stem Cells
3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K
Autoimmune Disorders
313
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
313
Introduction to Hemostasis
3.9K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
3.9K
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K


